KAYLEEN GRASHOFF: Open Payments
NPI 1487421251 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,670 in 102 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $1,496 · 2025 $1,670
Food & beverage: $1,670
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $368 |
| AstraZeneca Pharmaceuticals LP | 10 | $251 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $144 |
| Lilly USA, LLC | 9 | $136 |
| Sumitomo Pharma America, Inc. | 4 | $84 |
| Tris Pharma Inc | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| PFIZER INC. | 3 | $72 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Novo Nordisk Inc | 3 | $49 |
Products named: VRAYLAR, CAPLYTA, MOUNJARO, BREZTRI, AIRSUPRA, GEMTESA, Dyanavel XR, REXULTI.
Industry payments across IN — which companies pay providers there.
